Mongersen, an oral Smad7 antisense oligonucleotide, in patients with active Crohn’s disease

Lignende værker

• Mongersen, an oral Smad7 antisense oligonucleotide, in patients with active Crohn’s disease
  af: Sandro Ardizzone, et al.
  Udgivet: (2016-07-01)
• Impact of patient characteristics on the clinical efficacy of mongersen (GED‐0301), an oral Smad7 antisense oligonucleotide, in active Crohn's disease
  af: Monteleone, G., et al.
  Udgivet: (2016)
• Phase I Clinical Trial of Smad7 Knockdown Using Antisense Oligonucleotide in Patients With Active Crohn's Disease
  af: Monteleone, Giovanni, et al.
  Udgivet: (2012)
• A Novel Smad7 Genetic Variant Mapping on the Genomic Region Targeted by Mongersen Is Associated with Crohn’s Disease
  af: Di Fusco, Davide, et al.
  Udgivet: (2020)
• A Pharmacological Batch of Mongersen that Downregulates Smad7 is Effective as Induction Therapy in Active Crohn’s Disease: A Phase II, Open-Label Study
  af: Marafini, Irene, et al.
  Udgivet: (2021)